X-82 to Treat Age-related Macular Degeneration

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this study is to evaluate the safety and efficacy of X-82 in the treatment of vision loss due to wet AMD.
Epistemonikos ID: 1a0bc1ffd2686f5f7794139369df2aa2f282e3a9
First added on: May 12, 2024